Last update 08 May 2025

mRNA plus Lysate-loaded Dendritic Cell Vaccine(M.D. Anderson Cancer Center)

Overview

Basic Info

Drug Type
Therapeutic vaccine, Dendritic cell vaccine, mRNA vaccine
Synonyms-
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
NeoplasmsNervous System Diseases
Active Indication
Malignant glioma of brain
Inactive Indication
Hemangiosarcoma
Originator Organization
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center
Active Organization
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

Related

1
Clinical Trials associated with mRNA plus Lysate-loaded Dendritic Cell Vaccine(M.D. Anderson Cancer Center)
NCT05799612
/ WithdrawnPhase 1IIT
Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma
100 Clinical Results associated with mRNA plus Lysate-loaded Dendritic Cell Vaccine(M.D. Anderson Cancer Center)
Login to view more data
100 Translational Medicine associated with mRNA plus Lysate-loaded Dendritic Cell Vaccine(M.D. Anderson Cancer Center)
Login to view more data
100 Patents (Medical) associated with mRNA plus Lysate-loaded Dendritic Cell Vaccine(M.D. Anderson Cancer Center)
Login to view more data
100 Deals associated with mRNA plus Lysate-loaded Dendritic Cell Vaccine(M.D. Anderson Cancer Center)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HemangiosarcomaPreclinical
United States
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center
22 Mar 2024
Malignant glioma of brainPreclinical
United States
The University of Texas MD Anderson Cancer CenterThe University of Texas MD Anderson Cancer Center
27 Nov 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free